"My Health Priorities" Program for Rural and Underserved Older Adults With Multiple Chronic Conditions (MyHP-South)
Refinement and Pilot Testing of the "My Health Priorities" Program for Rural and Underserved Older Adults With Multiple Chronic Conditions in the Deep South (MyHP-South)
The goal of this clinical trial is to evaluate the feasibility and acceptability of the revised My Health Priorities (MyHP) program among rural and underserved older adults with multiple chronic conditions in the Deep South. The program is designed to help participants clarify their health-related values, as well as improve communication with family caregivers and healthcare providers to support medical decision-making. The main question this study aims to answer is whether the revised MyHP program is practical/easy for individuals to use, and if it helps support necessary conversations about healthcare priorities. Participants will be asked to complete the revised MyHP program over a Zoom or in-person session with their caregiver, as well as complete questionnaires over a telephone interview before and 12 weeks after the completion of the program. In addition to participating in the MyHP program, caregivers will also be asked to complete a series of questionnaires over a telephone interview before and 12 weeks after the program. Both patients and caregivers will also be asked to complete a brief survey about their experience with the program over a telephone interview.
Tutkimuksen yleiskatsaus
Tila
Tila
Ehdot
Ehdot
Interventio / Hoito
Interventio / Hoito
Opintotyyppi
Opintotyyppi
Ilmoittautuminen (Arvioitu)
Ilmoittautuminen
Vaihe
Vaihe
- Ei sovellettavissa
Yhteystiedot ja paikat
Opiskeluyhteys
Opiskeluyhteys
- Nimi: Alexis M Johnson, B.S.
- Puhelinnumero: 205-975-1864
- Sähköposti: amjohns2@uab.edu
Tutki yhteystietojen varmuuskopiointi
- Nimi: Deborah B Ejem, Ph.D.
- Puhelinnumero: 205-996-1671
- Sähköposti: tejem@uab.edu
Opiskelupaikat
-
-
Alabama
-
Birmingham, Alabama, Yhdysvallat, 35233
- The Whitaker Clinic of the University of Alabama at Birmingham (UAB) Hospital
-
Ottaa yhteyttä:
- Alexis M Johnson, B.S.
- Puhelinnumero: 205-975-1864
- Sähköposti: amjohns2@uab.edu
-
Ottaa yhteyttä:
- Deborah B Ejem, Ph.D.
- Puhelinnumero: 205-996-1671
- Sähköposti: tejem@uab.edu
-
-
Osallistumiskriteerit
Kelpoisuusvaatimukset
Kelpoisuusvaatimukset
Opintokelpoiset iät
Hyväksyy terveitä vapaaehtoisia
Sukupuolet, jotka voivat opiskella
Kuvaus
Inclusion Criteria for Patients:
- Identifies as African American or White/Caucasian
- Is 65 years of age or older
- Has at least two of the following chronic conditions: cancer, heart disease, kidney disease, liver disease, or lung disease
- English-speaking and able to complete baseline study measures
- Cognitively able to participate in decision-making discussions
- Has a family caregiver that meets the eligibility requirements
- Has reliable telephone access
Inclusion Criteria for Caregivers:
- Identifies as African American or White/Caucasian
- Is 18 years of age or older
- A relative, partner, or friend who provides unpaid assistance or support with health-related decision-making (may or may not live in the same residence)
- English-speaking and able to complete baseline study measures
- Cognitively able to participate in decision-making discussions
- Has reliable telephone access
Exclusion Criteria for Patients:
- Has a documented diagnosis of dementia
- Is unable to understand the study and provide informed consent
- Resides in a nursing home or assisted living facility
Exclusion Criteria for Caregivers:
- Is unable to understand the study and provide informed consent
- Is unable to communicate with research staff
- Is unable to participate in the dyadic MyHP-South session and required assessments
Opintosuunnitelma
Miten tutkimus on suunniteltu?
Suunnittelun yksityiskohdat
- Ensisijainen käyttötarkoitus: Terveyspalvelututkimus
- Jako: Ei käytössä
- Inventiomalli: Yksittäinen ryhmätehtävä
- Naamiointi: Ei mitään (avoin tarra)
Aseiden lukumäärä
Aseet ja interventiot
Osallistujaryhmä / ArmOsallistujaryhmä / Arm |
Interventio / HoitoInterventio / Hoito |
|---|---|
|
Kokeellinen: MyHP-South Users
Includes the patients and caregivers who will be utilizing the MyHP-South program, as well as evaluating its feasibility/accessibility based on clarity, cultural relevance, usability, content, and delivery. This arm also includes the clinicians who will be assessing the usefulness of the program in a primary care setting. |
Participants will use the refined My Health Priorities South (MyHP-South) program to help identify and communicate personal health priorities, then evaluate its feasibility/accessibility based on clarity, cultural relevance, usability, content, and delivery. |
Mitä tutkimuksessa mitataan?
Ensisijaiset tulostoimenpiteet
Ensisijaiset tulostoimenpiteet
Tulosmittaus |
Toimenpiteen kuvaus |
Aikaikkuna |
|---|---|---|
|
Patient System Usability Scale (SUS)
Aikaikkuna: At the MyHP-South session, within 14 days after baseline.
|
Over a Zoom or telephone interview, patients will answer ten questions regarding the accessibility/usability of the revised MyHP-South tool. Answer options will follow a ranked, Likert-type frequency scale, with answers ranging from 1: strongly disagree, to 5: strongly agree. |
At the MyHP-South session, within 14 days after baseline.
|
|
Acceptability Interview
Aikaikkuna: At the MyHP-South session, within 14 days after baseline.
|
Over a Zoom or telephone interview, both patients and caregivers will together answer 26 questions regarding their experience using the revised MyHP-South tool. Answer options will be open-ended. |
At the MyHP-South session, within 14 days after baseline.
|
|
Recruitment Feasibility
Aikaikkuna: From initiation of recruitment through enrollment of the final dyad (approximately 12 months).
|
Indicated by the number and proportion of eligible patient-caregiver dyads who enroll. |
From initiation of recruitment through enrollment of the final dyad (approximately 12 months).
|
|
Retention and Completion Feasibility
Aikaikkuna: From baseline through 12 weeks after the MyHP-South session.
|
Indicated by the number and proportion of enrolled dyads completing baseline assessments, the MyHP-South session, immediate post-session assessments, the acceptability interview, and the 12-week assessments. |
From baseline through 12 weeks after the MyHP-South session.
|
|
Caregiver System Usability Scale (SUS)
Aikaikkuna: Immediately after the MyHP-South session, during the same study visit.
|
Over a Zoom or telephone interview, caregivers will answer ten questions regarding the accessibility/usability of the revised MyHP-South tool. Answer options will follow a ranked, Likert-type frequency scale, with answers ranging from 1: strongly disagree, to 5: strongly agree. |
Immediately after the MyHP-South session, during the same study visit.
|
Toissijaiset tulostoimenpiteet
Toissijaiset tulostoimenpiteet
Tulosmittaus |
Toimenpiteen kuvaus |
Aikaikkuna |
|---|---|---|
|
CollaboRATE Scale Score
Aikaikkuna: At baseline and 12 weeks after the MyHP-South session.
|
Over a telephone interview, patients will answer three questions regarding their experience with their healthcare provider during a clinical encounter. Answer options will follow a ranked scale ranging from zero to nine and will then be calculated into a final score/percentage. |
At baseline and 12 weeks after the MyHP-South session.
|
|
Treatment Burden Questionnaire (TBQ) Score
Aikaikkuna: At baseline and 12 weeks after the MyHP-South session.
|
Over a telephone interview, patients will answer 13 questions regarding the potential burden of managing multiple chronic conditions. Answer options will follow a ranked scale ranging from zero to ten and will then be calculated into a final score. |
At baseline and 12 weeks after the MyHP-South session.
|
|
Patient Shared Care Instrument Score
Aikaikkuna: At baseline and 12 weeks after the MyHP-South session.
|
Over a telephone interview, patients will answer 19 questions regarding communication, decision making, and reciprocity with their caregiver. Answer options will follow a Likert-type frequency scale, which will be calculated into final scores for each of the three subscales. |
At baseline and 12 weeks after the MyHP-South session.
|
|
Bakas Caregiver Outcomes Scale (BCOS)
Aikaikkuna: At baseline and 12 weeks after the MyHP-South session.
|
Over a telephone interview, caregivers will answer 10 questions regarding potential life changes that have occurred as a result of serving as a caregiver. Answer options will follow a ranked, Likert-type frequency scale, with answers ranging from -3: changed for the worse, to +3: changed for the best. |
At baseline and 12 weeks after the MyHP-South session.
|
|
Older Patient Assessment of Chronic Illness Care (O-PACIC) Scale Score
Aikaikkuna: At baseline and 12 weeks after the MyHP-South session.
|
Over a telephone interview, patients will answer ten questions regarding the quality of medical care they have received over the past six months. Answer options will follow a Likert-type frequency scale, which will then be calculated into a final score. |
At baseline and 12 weeks after the MyHP-South session.
|
|
Caregiver Shared Care Instrument Score
Aikaikkuna: At baseline and 12 weeks after the MyHP-South session.
|
Over a telephone interview, caregivers will answer 19 questions regarding communication, decision making, and reciprocity with their patient. Answer options will follow a Likert-type frequency scale, which will be calculated into final scores for each of the three subscales. |
At baseline and 12 weeks after the MyHP-South session.
|
Muut tulostoimenpiteet
Muut tulostoimenpiteet
Tulosmittaus |
Toimenpiteen kuvaus |
Aikaikkuna |
|---|---|---|
|
Timing Log for MyHP-South Session
Aikaikkuna: At the MyHP-South session, within 14 days after baseline.
|
Research staff will document the length of each MyHP-South session by documenting what time the session started and what time the session ended. Time used to navigate technical difficulties will be subtracted. Tracking how long the session takes serves as a measure of feasibility. |
At the MyHP-South session, within 14 days after baseline.
|
|
Clinician Feedback Survey
Aikaikkuna: Within 6 months after the completion of the MyHP-South session.
|
Over an electronic survey, clinicians who provide care to enrolled patients will answer ten questions regarding the clarity, fit, and usefulness of the revised MyHP-South in a primary care setting. |
Within 6 months after the completion of the MyHP-South session.
|
Yhteistyökumppanit ja tutkijat
Sponsori
Sponsori
Yhteistyökumppanit
Yhteistyökumppanit
Tutkijat
Tutkijat
- Päätutkija: Deborah B Ejem, Ph.D., University of Alabama at Birmingham
Opintojen ennätyspäivät
Opi tärkeimmät päivämäärät
Opiskelun aloitus (Arvioitu)
Opiskelun aloitus
Ensisijainen valmistuminen (Arvioitu)
Ensisijainen valmistuminen
Opintojen valmistuminen (Arvioitu)
Opintojen valmistuminen
Opintoihin ilmoittautumispäivät
Ensimmäinen lähetetty
Ensimmäinen lähetetty
Ensimmäinen toimitettu, joka täytti QC-kriteerit
Ensimmäinen toimitettu, joka täytti QC-kriteerit
Ensimmäinen Lähetetty (Todellinen)
Ensimmäinen Lähetetty
Tutkimustietojen päivitykset
Viimeisin päivitys julkaistu (Todellinen)
Viimeisin päivitys julkaistu
Viimeisin lähetetty päivitys, joka täytti QC-kriteerit
Viimeisin lähetetty päivitys, joka täytti QC-kriteerit
Viimeksi vahvistettu
Viimeksi vahvistettu
Lisää tietoa
Tähän tutkimukseen liittyvät termit
Avainsanat
Muita asiaankuuluvia MeSH-ehtoja
Muut tutkimustunnusnumerot
Muut tutkimustunnusnumerot
- IRB-300016725
- U54AG093230 (Yhdysvaltain NIH-apuraha/sopimus)
- 606877 (Muu tunniste: ASSIST Study ID)
- DGCG-11797 (Muu tunniste: NIA CROMS Study ID)
Yksittäisten osallistujien tietojen suunnitelma (IPD)
Aiotko jakaa yksittäisten osallistujien tietoja (IPD)?
Lääke- ja laitetiedot, tutkimusasiakirjat
Tutkii yhdysvaltalaista FDA sääntelemää lääkevalmistetta
Tutkii yhdysvaltalaista FDA sääntelemää laitetuotetta
Nämä tiedot haettiin suoraan verkkosivustolta clinicaltrials.gov ilman muutoksia. Jos sinulla on pyyntöjä muuttaa, poistaa tai päivittää tutkimustietojasi, ota yhteyttä register@clinicaltrials.gov. Heti kun muutos on otettu käyttöön osoitteessa clinicaltrials.gov, se päivitetään automaattisesti myös verkkosivustollemme .